Formulary Committee members with a potential conflict of interest participation in committee communications and discussions authorization provision, public comment process for recommendations to the Formulary Committee development by the commissioner of human services requirement provision, and Minnesota Rare Disease Advisory Council expertise sought by the Formulary Committee requirement provision
Sponsored By: Liz Boldon (Democratic)
In Committee
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsor
Liz Boldon
Democratic • Senate
Cosponsors
Robert J. Kupec
Democratic • Senate
Bill Lieske
Republican • Senate
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
Referred to Health and Human Services
3/17/2025SenateIntroduction and first reading
3/17/2025Senate
Bill Text
Introduction
Related Bills
HF 5099 — Rosemount; new water treatment facility funding provided, bonds issued, and money appropriated.
SF 5249 — Constitutional amendment proposal to allow the lieutenant governor to cast a vote in the house of representatives in case of a tie
HF 5077 — Reduction to local government aid to a county or city that uses the incorrect state flag established.
SF 5250 — Metropolitan Mosquito Control District public health infrastructure appropriation and bond issuance authorization
HF 5102 — Motor vehicle registration tax modified.
SF 5248 — Elections provisions modification